C
Cellivery Therapeutics Inc
KOSDAQ:268600
Cellivery Therapeutics Inc
KOSDAQ:268600
Price:
6 680
KRW
-29.91%
Market Cap:
₩594.9m
Cash Flow Statement
Cash Flow Statement
Cellivery Therapeutics Inc
Cellivery Therapeutics Inc
Currency: KRW
| Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||||
| Net Income |
(9 800)
|
(9 553)
|
(6 698)
|
(13 403)
|
(16 670)
|
(20 468)
|
(19 650)
|
(14 965)
|
(16 082)
|
(17 263)
|
(17 248)
|
(18 310)
|
(21 029)
|
(25 031)
|
(28 069)
|
(39 894)
|
(48 561)
|
(54 567)
|
(75 159)
|
(74 245)
|
(70 955)
|
(61 091)
|
(34 036)
|
(21 400)
|
(9 917)
|
(6 557)
|
|
| Depreciation & Amortization |
235
|
369
|
507
|
672
|
757
|
878
|
998
|
982
|
1 035
|
1 042
|
1 039
|
1 057
|
1 092
|
1 157
|
1 461
|
2 225
|
3 215
|
4 314
|
5 195
|
5 388
|
5 739
|
5 167
|
4 950
|
4 523
|
0
|
3 910
|
|
| Other Non-Cash Items |
9 326
|
7 191
|
3 788
|
8 875
|
8 576
|
11 190
|
7 572
|
2 331
|
2 010
|
2 951
|
2 926
|
3 742
|
6 731
|
7 835
|
7 583
|
9 038
|
10 710
|
9 753
|
14 126
|
16 256
|
16 127
|
17 085
|
13 207
|
8 571
|
5 145
|
795
|
|
| Cash Taxes Paid |
6
|
9
|
14
|
30
|
42
|
58
|
87
|
87
|
(13)
|
(21)
|
(30)
|
(49)
|
(6)
|
(5)
|
(22)
|
(9)
|
13
|
47
|
152
|
138
|
(41)
|
(86)
|
(206)
|
(208)
|
(2)
|
(3)
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
58
|
116
|
172
|
217
|
235
|
215
|
390
|
864
|
1 125
|
1 503
|
1 833
|
1 341
|
1 097
|
1 125
|
1 006
|
979
|
|
| Change in Working Capital |
2 604
|
2 383
|
(237)
|
1 863
|
(705)
|
(951)
|
(501)
|
(1 610)
|
(781)
|
(858)
|
(2 813)
|
(1 576)
|
(3 129)
|
(2 779)
|
(3 719)
|
(6 316)
|
(9 469)
|
(10 956)
|
(544)
|
1 846
|
11 991
|
13 126
|
7 088
|
7 066
|
2 162
|
3 847
|
|
| Cash from Operating Activities |
2 155
N/A
|
180
-92%
|
(2 639)
N/A
|
(1 994)
+24%
|
(8 041)
-303%
|
(9 351)
-16%
|
(11 581)
-24%
|
(13 263)
-15%
|
(13 818)
-4%
|
(14 127)
-2%
|
(16 097)
-14%
|
(15 087)
+6%
|
(16 335)
-8%
|
(18 818)
-15%
|
(22 744)
-21%
|
(34 947)
-54%
|
(44 105)
-26%
|
(51 456)
-17%
|
(56 381)
-10%
|
(50 756)
+10%
|
(37 098)
+27%
|
(25 713)
+31%
|
(8 791)
+66%
|
(1 240)
+86%
|
(534)
+57%
|
1 185
N/A
|
|
| Investing Cash Flow | |||||||||||||||||||||||||||
| Capital Expenditures |
(587)
|
(645)
|
(675)
|
(1 037)
|
(1 042)
|
(1 014)
|
(725)
|
(534)
|
(324)
|
(559)
|
(1 241)
|
(1 427)
|
(1 803)
|
(1 849)
|
(4 590)
|
(8 822)
|
(15 407)
|
(17 641)
|
(17 649)
|
(13 072)
|
(6 096)
|
(3 562)
|
(64)
|
0
|
(2)
|
0
|
|
| Other Items |
(1 444)
|
(1 739)
|
(33 263)
|
(33 609)
|
(26 443)
|
(28 032)
|
9 592
|
12 673
|
9 280
|
(16 307)
|
(663)
|
(24 904)
|
(7 857)
|
5 214
|
(3 959)
|
(26 998)
|
(38 543)
|
2 285
|
13 134
|
59 803
|
50 319
|
24 255
|
3 951
|
2 086
|
1 276
|
1 012
|
|
| Cash from Investing Activities |
(2 031)
N/A
|
(2 385)
-17%
|
(33 938)
-1 323%
|
(34 647)
-2%
|
(27 485)
+21%
|
(29 046)
-6%
|
8 867
N/A
|
12 139
+37%
|
8 956
-26%
|
(16 866)
N/A
|
(1 905)
+89%
|
(26 332)
-1 283%
|
(9 660)
+63%
|
3 365
N/A
|
(8 549)
N/A
|
(35 819)
-319%
|
(53 949)
-51%
|
(15 356)
+72%
|
(4 514)
+71%
|
46 731
N/A
|
44 223
-5%
|
20 693
-53%
|
3 887
-81%
|
2 084
-46%
|
1 274
-39%
|
1 020
-20%
|
|
| Financing Cash Flow | |||||||||||||||||||||||||||
| Net Issuance of Common Stock |
6 497
|
6 497
|
35 852
|
38 702
|
32 673
|
32 673
|
3 318
|
468
|
2 164
|
23 162
|
23 326
|
0
|
26 182
|
5 476
|
40 311
|
0
|
0
|
0
|
2 498
|
0
|
0
|
0
|
2 295
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
(132)
|
(166)
|
(249)
|
(341)
|
(301)
|
(359)
|
22 632
|
22 632
|
22 631
|
22 628
|
(375)
|
33 116
|
35 645
|
40 016
|
39 465
|
3 673
|
(1 940)
|
(9 617)
|
(8 493)
|
(10 508)
|
(7 793)
|
(4 635)
|
(4 817)
|
|
| Other |
(0)
|
(1)
|
(1 762)
|
(1 762)
|
(1 762)
|
(1 762)
|
(0)
|
(0)
|
(2)
|
(516)
|
(516)
|
(577)
|
(579)
|
(69)
|
(1 486)
|
0
|
0
|
(1 465)
|
(54)
|
(57)
|
(57)
|
(9)
|
(3)
|
0
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
6 497
N/A
|
6 496
0%
|
34 090
+425%
|
36 807
+8%
|
30 744
-16%
|
30 662
0%
|
2 976
-90%
|
167
-94%
|
1 803
+982%
|
45 278
+2 412%
|
45 442
+0%
|
45 380
0%
|
48 231
+6%
|
5 031
-90%
|
71 941
+1 330%
|
74 531
+4%
|
73 887
-1%
|
72 999
-1%
|
6 117
-92%
|
502
-92%
|
(7 176)
N/A
|
(6 004)
+16%
|
(8 216)
-37%
|
(5 498)
+33%
|
(2 340)
+57%
|
(2 522)
-8%
|
|
| Change in Cash | |||||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(3)
|
(11)
|
0
|
(5)
|
(8)
|
0
|
0
|
1
|
(0)
|
1
|
(7)
|
(5)
|
(4)
|
(2)
|
(1)
|
50
|
28
|
13
|
31
|
(2)
|
11
|
7
|
0
|
0
|
(15)
|
0
|
|
| Net Change in Cash |
6 617
N/A
|
4 281
-35%
|
(2 487)
N/A
|
162
N/A
|
(4 789)
N/A
|
(7 736)
-62%
|
262
N/A
|
(956)
N/A
|
(3 059)
-220%
|
14 287
N/A
|
27 434
+92%
|
3 957
-86%
|
22 232
+462%
|
(10 425)
N/A
|
40 647
N/A
|
3 815
-91%
|
(24 140)
N/A
|
6 200
N/A
|
(54 748)
N/A
|
(3 525)
+94%
|
(40)
+99%
|
(11 016)
-27 347%
|
(13 119)
-19%
|
(4 654)
+65%
|
(1 614)
+65%
|
(317)
+80%
|
|
| Free Cash Flow | |||||||||||||||||||||||||||
| Free Cash Flow |
1 568
N/A
|
(465)
N/A
|
(3 315)
-613%
|
(3 031)
+9%
|
(9 083)
-200%
|
(10 365)
-14%
|
(12 306)
-19%
|
(13 797)
-12%
|
(14 142)
-3%
|
(14 686)
-4%
|
(17 338)
-18%
|
(16 514)
+5%
|
(18 138)
-10%
|
(20 667)
-14%
|
(27 334)
-32%
|
(43 769)
-60%
|
(59 512)
-36%
|
(69 096)
-16%
|
(74 030)
-7%
|
(63 828)
+14%
|
(43 194)
+32%
|
(29 275)
+32%
|
(8 855)
+70%
|
(1 240)
+86%
|
(535)
+57%
|
1 185
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
